HK1158700A1 - Methods and compositions for detecting autoimmune disorders - Google Patents

Methods and compositions for detecting autoimmune disorders

Info

Publication number
HK1158700A1
HK1158700A1 HK11112866.3A HK11112866A HK1158700A1 HK 1158700 A1 HK1158700 A1 HK 1158700A1 HK 11112866 A HK11112866 A HK 11112866A HK 1158700 A1 HK1158700 A1 HK 1158700A1
Authority
HK
Hong Kong
Prior art keywords
compositions
autoimmune disorders
methods
detecting autoimmune
detecting
Prior art date
Application number
HK11112866.3A
Other languages
English (en)
Chinese (zh)
Inventor
Alexander Abbas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1158700A1 publication Critical patent/HK1158700A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK11112866.3A 2005-08-05 2011-11-28 Methods and compositions for detecting autoimmune disorders HK1158700A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70620505P 2005-08-05 2005-08-05

Publications (1)

Publication Number Publication Date
HK1158700A1 true HK1158700A1 (en) 2012-07-20

Family

ID=37663302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11112866.3A HK1158700A1 (en) 2005-08-05 2011-11-28 Methods and compositions for detecting autoimmune disorders

Country Status (12)

Country Link
US (3) US20070092890A1 (xx)
EP (2) EP1945800B1 (xx)
AT (1) ATE549416T1 (xx)
AU (1) AU2006278561C1 (xx)
CA (1) CA2614455A1 (xx)
DK (1) DK2327792T3 (xx)
ES (2) ES2432026T3 (xx)
HK (1) HK1158700A1 (xx)
PL (1) PL2327792T3 (xx)
PT (1) PT2327792E (xx)
SI (1) SI2327792T1 (xx)
WO (1) WO2007019219A2 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080057503A1 (en) 2006-04-24 2008-03-06 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
BRPI0720035A2 (pt) * 2006-12-06 2019-05-07 Medimmune, Llc métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit
US20100261172A1 (en) * 2007-05-03 2010-10-14 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
JP5411129B2 (ja) * 2007-05-03 2014-02-12 メディミューン，エルエルシー インターフェロンα誘導性薬力学的マーカー
WO2008144761A2 (en) 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
WO2009061818A1 (en) * 2007-11-05 2009-05-14 Medimmune, Llc Methods of treating scleroderma
ES2529593T3 (es) * 2008-02-08 2015-02-23 Medimmune, Llc Marcadores de enfermedades y usos de los mismos
KR20120101340A (ko) * 2009-09-03 2012-09-13 메디뮨 엘엘씨 1형 인터페론 진단
EP2478356A1 (en) * 2009-09-18 2012-07-25 Rutgers, The State University High-throughput biomarker segmentation utilizing hierarchical normalized cuts
CN106929568A (zh) 2009-10-07 2017-07-07 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8824769B2 (en) * 2009-10-16 2014-09-02 General Electric Company Process and system for analyzing the expression of biomarkers in a cell
ES2372762B1 (es) * 2010-07-02 2012-11-28 Consejo Superior De Investigaciones Científicas (Csic) Método y kit para la detección de la activación de interferón y la respuesta inflamatoria independiente de interferón.
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS
WO2016179268A1 (en) * 2015-05-05 2016-11-10 University Of Florida Research Foundation, Inc. Diagnostic microarray, system and method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6214790B1 (en) * 1998-04-10 2001-04-10 Mayo Foundation For Medical Education And Research Neo-tryptophan
US20020081597A1 (en) 2000-03-31 2002-06-27 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
US20030148298A1 (en) * 2001-04-03 2003-08-07 O''toole Margot Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
AU2003299503A1 (en) * 2002-05-16 2004-06-15 Vanderbilt University Method for predicting autoimmune diseases
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
US20070048301A1 (en) * 2002-11-26 2007-03-01 Bodary-Winter Sarah C Compositions and methods for the treatment of immune related diseases
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005123113A2 (en) * 2004-06-14 2005-12-29 Intermune, Inc. Interferon compositions and methods of use thereof
WO2006020899A2 (en) * 2004-08-13 2006-02-23 Metrigenix Corporation Markers for autoimmune disease detection
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus

Also Published As

Publication number Publication date
US20100279298A1 (en) 2010-11-04
WO2007019219A2 (en) 2007-02-15
AU2006278561C1 (en) 2013-05-02
DK2327792T3 (da) 2014-01-13
EP2327792B9 (en) 2013-12-18
PL2327792T3 (pl) 2014-03-31
CA2614455A1 (en) 2007-02-15
ES2383966T3 (es) 2012-06-27
ATE549416T1 (de) 2012-03-15
AU2006278561A1 (en) 2007-02-15
EP2327792B1 (en) 2013-10-02
US20070092890A1 (en) 2007-04-26
EP1945800B1 (en) 2012-03-14
WO2007019219A3 (en) 2007-05-31
SI2327792T1 (sl) 2013-12-31
PT2327792E (pt) 2013-11-21
EP1945800A2 (en) 2008-07-23
ES2432026T3 (es) 2013-11-29
AU2006278561B2 (en) 2012-11-01
US20080318800A1 (en) 2008-12-25
EP2327792A1 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
HK1158700A1 (en) Methods and compositions for detecting autoimmune disorders
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
TW200727920A (en) New regimens for oral monophasic contraceptives
GB0502396D0 (en) Tapping the vacume 1
EP1918370A4 (en) ANTIGEN PCNA MUTANT
IL184834A0 (en) Compositions and methods for the manufacture thereof
WO2006098998A3 (en) Methods and compositions for modulating vascular integrity
IL185997A0 (en) Substituted aryl 1.4-pyrazine derivatives background of the invention
GB0502992D0 (en) The ballcaster
EP1906960A4 (en) NEW COMBINATION 1
WO2005118859A3 (en) Carrier tests for albinism in the cat
GB0414760D0 (en) The alternative
IL189803A0 (en) Device for determining the relative position between two essentially flat elements
WO2006064517A3 (en) Methods for the purification of 20(s)-camptothecin
GB0523899D0 (en) The one
PL1649947T3 (pl) Urządzenie do mechanicznego łączenia części lub czegoś podobnego
GB0511610D0 (en) The motor-roll-off
GB0510227D0 (en) F e-2.1
PL375122A1 (pl) Statyw szynowy
GB0413574D0 (en) An invention for power-producing
TW200706179A (en) A composition for immunosuppression
GB0500806D0 (en) Munchies on the move
AU2005903753A0 (en) The rail grabber
GB0413113D0 (en) The sliding scale
GB0518344D0 (en) I c v t 2005

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180802